Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

Misbah Noshela Ghazanfar; Simon Francis Thomsen

doi:10.1080/09546634.2018.1515465

Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

Misbah Noshela Ghazanfar, Simon Francis Thomsen

3 Citations (Scopus)

Abstract

We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

Original language	English
Journal	Journal of Dermatological Treatment
Volume	30
Issue number	4
Pages (from-to)	387-388
ISSN	0954-6634
DOIs	https://doi.org/10.1080/09546634.2018.1515465
Publication status	Published - 19 May 2019

Keywords

Omalizumab
combined biologic therapy
etanercept
CSU

Access to Document

10.1080/09546634.2018.1515465

Cite this

@article{7c6c4d778740499e860c4ea3e53483ca,

title = "Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis",

abstract = "We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.",

keywords = "Omalizumab, combined biologic therapy, etanercept, CSU",

author = "Ghazanfar, {Misbah Noshela} and Thomsen, {Simon Francis}",

year = "2019",

month = may,

day = "19",

doi = "10.1080/09546634.2018.1515465",

language = "English",

volume = "30",

pages = "387--388",

journal = "Journal of Dermatological Treatment",

issn = "0954-6634",

publisher = "Taylor & Francis",

number = "4",

}

TY - JOUR

T1 - Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

AU - Ghazanfar, Misbah Noshela

AU - Thomsen, Simon Francis

PY - 2019/5/19

Y1 - 2019/5/19

N2 - We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

AB - We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

KW - Omalizumab

KW - combined biologic therapy

KW - etanercept

KW - CSU

U2 - 10.1080/09546634.2018.1515465

DO - 10.1080/09546634.2018.1515465

M3 - Journal article

C2 - 30132352

SN - 0954-6634

VL - 30

SP - 387

EP - 388

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

IS - 4

ER -